Patel Naimish 4
4 · CRISPR Therapeutics AG · Filed Jun 3, 2025
Insider Transaction Report
Form 4
Patel Naimish
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2025-05-30+25,000→ 25,000 total→ Common Shares (25,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028.